Literature DB >> 16219674

Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor.

Anna Jurewicz1, Mariola Matysiak, Krzysztof Tybor, Lukasz Kilianek, Cedric S Raine, Krzysztof Selmaj.   

Abstract

Tumour necrosis factor (TNF)-induced death of oligodendrocytes, the cell type targeted in multiple sclerosis, is mediated by TNF receptor p55 (TNFR-p55). The ligation of TNFR-p55 induces several signal transduction pathways; however, the precise mechanism involved in human oligodendrocyte (hOL) death is unknown. We defined that TNF-induced death of hOLs is non-caspase dependent, as evidenced by lack of generation of caspases 8, 1 and 3 active subunits; lack of cleavage of caspases 1 and 3 fluorogenic substrates; and lack of hOL death inhibition by the general caspase inhibitor, ZVAD.FMK. Electrophoresis of TNF-exposed hOL DNA revealed large-scale DNA fragmentation characteristic of apoptosis-inducing factor (AIF)-mediated cell death, and co-localization experiments showed that AIF translocation to the nucleus occurred upon exposure to TNF. AIF depletion by an antisense strategy prevented TNF-induced hOL death. These results indicate that TNF-induced death of hOLs is dependent on AIF, information of significance for the design strategies to protect hOLs during immune-mediated demyelination.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16219674     DOI: 10.1093/brain/awh627

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  48 in total

1.  Effects of irradiation on the postnatal development of the brain in a genetic mouse model of globoid cell leukodystrophy.

Authors:  Francesca Galbiati; Giulia Clementi; Daniela Superchi; Maria I Givogri; Ernesto R Bongarzone
Journal:  Neurochem Res       Date:  2007-01-03       Impact factor: 3.996

2.  Multiple sclerosis: death receptor expression and oligodendrocyte apoptosis in established lesions.

Authors:  Barbara Cannella; Stefanie Gaupp; Kakuri M Omari; Cedric S Raine
Journal:  J Neuroimmunol       Date:  2007-07-05       Impact factor: 3.478

3.  Microglial inhibitory factor (MIF/TKP) mitigates secondary damage following spinal cord injury.

Authors:  Jaime Emmetsberger; Stella E Tsirka
Journal:  Neurobiol Dis       Date:  2012-05-14       Impact factor: 5.996

4.  Effects of sleep and wake on oligodendrocytes and their precursors.

Authors:  Michele Bellesi; Martha Pfister-Genskow; Stephanie Maret; Sunduz Keles; Giulio Tononi; Chiara Cirelli
Journal:  J Neurosci       Date:  2013-09-04       Impact factor: 6.167

5.  Astrocytes promote TNF-mediated toxicity to oligodendrocyte precursors.

Authors:  Sunja Kim; Andrew J Steelman; Hisami Koito; Jianrong Li
Journal:  J Neurochem       Date:  2010-12-02       Impact factor: 5.372

6.  Dysregulated RNA-Induced Silencing Complex (RISC) Assembly within CNS Corresponds with Abnormal miRNA Expression during Autoimmune Demyelination.

Authors:  Przemysław Lewkowicz; Hanna Cwiklińska; Marcin P Mycko; Maria Cichalewska; Małgorzata Domowicz; Natalia Lewkowicz; Anna Jurewicz; Krzysztof W Selmaj
Journal:  J Neurosci       Date:  2015-05-13       Impact factor: 6.167

7.  cFLIP is critical for oligodendrocyte protection from inflammation.

Authors:  D C Tanner; A Campbell; K M O'Banion; M Noble; M Mayer-Pröschel
Journal:  Cell Death Differ       Date:  2015-01-30       Impact factor: 15.828

8.  Microglial CD14 activated by iNOS contributes to neuroinflammation in cerebral ischemia.

Authors:  Mian Zhou; Christie M Wang; Weng-Lang Yang; Ping Wang
Journal:  Brain Res       Date:  2013-02-14       Impact factor: 3.252

9.  Mathematical modelling of cell-fate decision in response to death receptor engagement.

Authors:  Laurence Calzone; Laurent Tournier; Simon Fourquet; Denis Thieffry; Boris Zhivotovsky; Emmanuel Barillot; Andrei Zinovyev
Journal:  PLoS Comput Biol       Date:  2010-03-05       Impact factor: 4.475

Review 10.  Oligodendrocytes: biology and pathology.

Authors:  Monika Bradl; Hans Lassmann
Journal:  Acta Neuropathol       Date:  2009-10-22       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.